125 related articles for article (PubMed ID: 32499156)
1. Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI Radiomics: A Preliminary Investigation.
Eresen A; Yang J; Shangguan J; Benson AB; Yaghmai V; Zhang Z
Acad Radiol; 2021 Jun; 28(6):e147-e154. PubMed ID: 32499156
[TBL] [Abstract][Full Text] [Related]
2. MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma.
Eresen A; Yang J; Shangguan J; Li Y; Hu S; Sun C; Velichko Y; Yaghmai V; Benson AB; Zhang Z
J Transl Med; 2020 Feb; 18(1):61. PubMed ID: 32039734
[TBL] [Abstract][Full Text] [Related]
3. Prediction of therapeutic outcome and survival in a transgenic mouse model of pancreatic ductal adenocarcinoma treated with dendritic cell vaccination or CDK inhibitor using MRI texture: a feasibility study.
Eresen A; Yang J; Shangguan J; Li Y; Hu S; Sun C; Yaghmai V; Benson Iii AB; Zhang Z
Am J Transl Res; 2020; 12(5):2201-2211. PubMed ID: 32509212
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-Kras
Hu S; Pan L; Shangguan J; Figini M; Eresen A; Sun C; Wang B; Ma Q; Hu C; Yaghmai V; Velichko Y; Yang J; Zhang Z
J Immunol Methods; 2019 Feb; 465():1-6. PubMed ID: 30468734
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.
Yang J; Hu S; Shangguan J; Eresen A; Li Y; Pan L; Ma Q; Velichko Y; Wang J; Hu C; Yaghmai V; Zhang Z
Am J Cancer Res; 2019; 9(11):2456-2468. PubMed ID: 31815046
[TBL] [Abstract][Full Text] [Related]
6. Dinaciclib prolongs survival in the
Yang J; Hu S; Shangguan J; Eresen A; Li Y; Ma Q; Yaghmai V; Benson Iii AB; Zhang Z
Am J Transl Res; 2020; 12(3):1031-1043. PubMed ID: 32269732
[TBL] [Abstract][Full Text] [Related]
7. MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma.
Yu G; Zhang Z; Eresen A; Hou Q; Garcia EE; Yu Z; Abi-Jaoudeh N; Yaghmai V; Zhang Z
J Transl Med; 2024 Jan; 22(1):76. PubMed ID: 38243292
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging biomarkers for pulsed focused ultrasound treatment of pancreatic ductal adenocarcinoma.
Maloney E; Wang YN; Vohra R; Son H; Whang S; Khokhlova T; Park J; Gravelle K; Totten S; Hwang JH; Lee D
World J Gastroenterol; 2020 Mar; 26(9):904-917. PubMed ID: 32206002
[TBL] [Abstract][Full Text] [Related]
9. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
[TBL] [Abstract][Full Text] [Related]
10. Early Differentiation of Irreversible Electroporation Ablation Regions With Radiomics Features of Conventional MRI.
Eresen A; Sun C; Zhou K; Shangguan J; Wang B; Pan L; Hu S; Ma Q; Yang J; Zhang Z; Yaghmai V
Acad Radiol; 2022 Sep; 29(9):1378-1386. PubMed ID: 34933803
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell-based adoptive transfer immunotherapy for pancreatic ductal adenocarcinoma in a
Hu S; Yang J; Shangguan J; Eresen A; Li Y; Ma Q; Yaghmai V; Velichko Y; Hu C; Zhang Z
Am J Cancer Res; 2019; 9(8):1757-1765. PubMed ID: 31497356
[TBL] [Abstract][Full Text] [Related]
12. Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance.
Ariston Gabriel AN; Jiao Q; Yvette U; Yang X; Al-Ameri SA; Du L; Wang YS; Wang C
Pancreatology; 2020 Jan; 20(1):79-88. PubMed ID: 31780287
[TBL] [Abstract][Full Text] [Related]
13. α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
Verma RK; Yu W; Shrivastava A; Shankar S; Srivastava RK
Sci Rep; 2016 Sep; 6():32743. PubMed ID: 27624879
[TBL] [Abstract][Full Text] [Related]
14. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
[TBL] [Abstract][Full Text] [Related]
15. Classification of pulmonary lesion based on multiparametric MRI: utility of radiomics and comparison of machine learning methods.
Wang X; Wan Q; Chen H; Li Y; Li X
Eur Radiol; 2020 Aug; 30(8):4595-4605. PubMed ID: 32222795
[TBL] [Abstract][Full Text] [Related]
16. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.
Iida-Norita R; Kawamura M; Suzuki Y; Hamada S; Masamune A; Furukawa T; Sato Y
Cancer Sci; 2019 Jul; 110(7):2296-2308. PubMed ID: 31074083
[TBL] [Abstract][Full Text] [Related]
17. IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.
Long KB; Tooker G; Tooker E; Luque SL; Lee JW; Pan X; Beatty GL
Mol Cancer Ther; 2017 Sep; 16(9):1898-1908. PubMed ID: 28611107
[TBL] [Abstract][Full Text] [Related]
18. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
[TBL] [Abstract][Full Text] [Related]
19. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
[TBL] [Abstract][Full Text] [Related]
20. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer.
Waldmann J; Fendrich V; Reichert M; Hecker A; Bartsch DK; Padberg W; Holler JPN
J Surg Res; 2018 Mar; 223():230-236. PubMed ID: 29433879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
